PDB Short entry for 5CEP HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-JUL-15 5CEP TITLE DLK IN COMPLEX WITH INHIBITOR N-(1-ISOPROPYL-5-(PIPERIDIN-4-YL)-1H- TITLE 2 PYRAZOL-3-YL)-4-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 115-402); COMPND 5 SYNONYM: DUAL LEUCINE ZIPPER BEARING KINASE,DLK,LEUCINE-ZIPPER COMPND 6 PROTEIN KINASE,ZPK,MAPK-UPSTREAM KINASE,MUK,MIXED LINEAGE KINASE; COMPND 7 EC: 2.7.11.25; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP3K12, ZPK; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HI5; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.F.HARRIS,J.YIN REVDAT 3 06-MAR-24 5CEP 1 JRNL REMARK REVDAT 2 04-NOV-15 5CEP 1 JRNL REVDAT 1 14-OCT-15 5CEP 0 JRNL AUTH S.PATEL,S.F.HARRIS,P.GIBBONS,G.DESHMUKH,A.GUSTAFSON, JRNL AUTH 2 T.KELLAR,H.LIN,X.LIU,Y.LIU,Y.LIU,C.MA,K.SCEARCE-LEVIE, JRNL AUTH 3 A.S.GHOSH,Y.G.SHIN,H.SOLANOY,J.WANG,B.WANG,J.YIN,M.SIU, JRNL AUTH 4 J.W.LEWCOCK JRNL TITL SCAFFOLD-HOPPING AND STRUCTURE-BASED DISCOVERY OF POTENT, JRNL TITL 2 SELECTIVE, AND BRAIN PENETRANT JRNL TITL 3 N-(1H-PYRAZOL-3-YL)PYRIDIN-2-AMINE INHIBITORS OF DUAL JRNL TITL 4 LEUCINE ZIPPER KINASE (DLK, MAP3K12). JRNL REF J.MED.CHEM. V. 58 8182 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26431428 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01072 REMARK 2 REMARK 2 RESOLUTION. 1.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.09 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 17925 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910 REMARK 3 FREE R VALUE TEST SET COUNT : 881 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.99 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.11 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.73 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2865 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2151 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2725 REMARK 3 BIN R VALUE (WORKING SET) : 0.2138 REMARK 3 BIN FREE R VALUE : 0.2405 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.89 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 140 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2156 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 156 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.67310 REMARK 3 B22 (A**2) : 3.05070 REMARK 3 B33 (A**2) : -8.72380 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.76420 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.214 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.188 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.169 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.183 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.168 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2266 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3083 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 781 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 49 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 339 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2266 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 283 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2785 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.92 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.51 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5CEP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000211489. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.2.8 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18040 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 39.620 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MAGNESIUM ACETATE, 20% PEG 3350, REMARK 280 0.1 M HEPES PH 7.7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 19.80850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 112 REMARK 465 GLY A 113 REMARK 465 SER A 114 REMARK 465 GLU A 115 REMARK 465 ASP A 116 REMARK 465 THR A 257 REMARK 465 SER A 258 REMARK 465 LYS A 259 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 SER A 262 REMARK 465 ASP A 263 REMARK 465 LYS A 264 REMARK 465 SER A 265 REMARK 465 THR A 266 REMARK 465 LYS A 267 REMARK 465 MET A 268 REMARK 465 SER A 269 REMARK 465 SER A 399 REMARK 465 GLU A 400 REMARK 465 GLY A 401 REMARK 465 THR A 402 REMARK 465 GLY A 403 REMARK 465 ASN A 404 REMARK 465 SER A 405 REMARK 465 HIS A 406 REMARK 465 HIS A 407 REMARK 465 HIS A 408 REMARK 465 HIS A 409 REMARK 465 HIS A 410 REMARK 465 HIS A 411 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 185 37.36 -88.99 REMARK 500 ARG A 235 -18.56 77.57 REMARK 500 THR A 273 -4.84 -146.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 50E A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5CEN RELATED DB: PDB REMARK 900 RELATED ID: 5CEO RELATED DB: PDB REMARK 900 RELATED ID: 5CEQ RELATED DB: PDB DBREF 5CEP A 115 402 UNP Q12852 M3K12_HUMAN 115 402 SEQADV 5CEP MET A 112 UNP Q12852 INITIATING METHIONINE SEQADV 5CEP GLY A 113 UNP Q12852 EXPRESSION TAG SEQADV 5CEP SER A 114 UNP Q12852 EXPRESSION TAG SEQADV 5CEP GLY A 403 UNP Q12852 EXPRESSION TAG SEQADV 5CEP ASN A 404 UNP Q12852 EXPRESSION TAG SEQADV 5CEP SER A 405 UNP Q12852 EXPRESSION TAG SEQADV 5CEP HIS A 406 UNP Q12852 EXPRESSION TAG SEQADV 5CEP HIS A 407 UNP Q12852 EXPRESSION TAG SEQADV 5CEP HIS A 408 UNP Q12852 EXPRESSION TAG SEQADV 5CEP HIS A 409 UNP Q12852 EXPRESSION TAG SEQADV 5CEP HIS A 410 UNP Q12852 EXPRESSION TAG SEQADV 5CEP HIS A 411 UNP Q12852 EXPRESSION TAG SEQRES 1 A 300 MET GLY SER GLU ASP LEU TRP GLU VAL PRO PHE GLU GLU SEQRES 2 A 300 ILE LEU ASP LEU GLN TRP VAL GLY SER GLY ALA GLN GLY SEQRES 3 A 300 ALA VAL PHE LEU GLY ARG PHE HIS GLY GLU GLU VAL ALA SEQRES 4 A 300 VAL LYS LYS VAL ARG ASP LEU LYS GLU THR ASP ILE LYS SEQRES 5 A 300 HIS LEU ARG LYS LEU LYS HIS PRO ASN ILE ILE THR PHE SEQRES 6 A 300 LYS GLY VAL CYS THR GLN ALA PRO CYS TYR CYS ILE LEU SEQRES 7 A 300 MET GLU PHE CYS ALA GLN GLY GLN LEU TYR GLU VAL LEU SEQRES 8 A 300 ARG ALA GLY ARG PRO VAL THR PRO SER LEU LEU VAL ASP SEQRES 9 A 300 TRP SER MET GLY ILE ALA GLY GLY MET ASN TYR LEU HIS SEQRES 10 A 300 LEU HIS LYS ILE ILE HIS ARG ASP LEU LYS SER PRO ASN SEQRES 11 A 300 MET LEU ILE THR TYR ASP ASP VAL VAL LYS ILE SER ASP SEQRES 12 A 300 PHE GLY THR SER LYS GLU LEU SER ASP LYS SER THR LYS SEQRES 13 A 300 MET SER PHE ALA GLY THR VAL ALA TRP MET ALA PRO GLU SEQRES 14 A 300 VAL ILE ARG ASN GLU PRO VAL SER GLU LYS VAL ASP ILE SEQRES 15 A 300 TRP SER PHE GLY VAL VAL LEU TRP GLU LEU LEU THR GLY SEQRES 16 A 300 GLU ILE PRO TYR LYS ASP VAL ASP SER SER ALA ILE ILE SEQRES 17 A 300 TRP GLY VAL GLY SER ASN SER LEU HIS LEU PRO VAL PRO SEQRES 18 A 300 SER SER CYS PRO ASP GLY PHE LYS ILE LEU LEU ARG GLN SEQRES 19 A 300 CYS TRP ASN SER LYS PRO ARG ASN ARG PRO SER PHE ARG SEQRES 20 A 300 GLN ILE LEU LEU HIS LEU ASP ILE ALA SER ALA ASP VAL SEQRES 21 A 300 LEU SER THR PRO GLN GLU THR TYR PHE LYS SER GLN ALA SEQRES 22 A 300 GLU TRP ARG GLU GLU VAL LYS LEU HIS PHE GLU LYS ILE SEQRES 23 A 300 LYS SER GLU GLY THR GLY ASN SER HIS HIS HIS HIS HIS SEQRES 24 A 300 HIS HET 50E A 501 25 HETNAM 50E N-(5-PIPERIDIN-4-YL-1-PROPAN-2-YL-PYRAZOL-3-YL)-4- HETNAM 2 50E (TRIFLUOROMETHYL)PYRIDIN-2-AMINE FORMUL 2 50E C17 H22 F3 N5 FORMUL 3 HOH *156(H2 O) HELIX 1 AA1 PRO A 121 ILE A 125 5 5 HELIX 2 AA2 ASP A 156 ASP A 161 5 6 HELIX 3 AA3 ILE A 162 ARG A 166 5 5 HELIX 4 AA4 LEU A 198 ALA A 204 1 7 HELIX 5 AA5 THR A 209 HIS A 230 1 22 HELIX 6 AA6 LYS A 238 PRO A 240 5 3 HELIX 7 AA7 THR A 273 MET A 277 5 5 HELIX 8 AA8 ALA A 278 ARG A 283 1 6 HELIX 9 AA9 LYS A 290 GLY A 306 1 17 HELIX 10 AB1 ASP A 314 SER A 324 1 11 HELIX 11 AB2 PRO A 336 TRP A 347 1 12 HELIX 12 AB3 LYS A 350 ARG A 354 5 5 HELIX 13 AB4 SER A 356 SER A 373 1 18 HELIX 14 AB5 PRO A 375 LYS A 398 1 24 SHEET 1 AA1 5 LEU A 126 GLY A 134 0 SHEET 2 AA1 5 GLY A 137 PHE A 144 -1 O ARG A 143 N LEU A 126 SHEET 3 AA1 5 GLU A 147 LYS A 153 -1 O VAL A 151 N PHE A 140 SHEET 4 AA1 5 CYS A 187 GLU A 191 -1 O ILE A 188 N LYS A 152 SHEET 5 AA1 5 PHE A 176 CYS A 180 -1 N GLY A 178 O LEU A 189 SHEET 1 AA2 3 GLY A 196 GLN A 197 0 SHEET 2 AA2 3 MET A 242 ILE A 244 -1 O ILE A 244 N GLY A 196 SHEET 3 AA2 3 VAL A 250 ILE A 252 -1 O LYS A 251 N LEU A 243 CISPEP 1 SER A 133 GLY A 134 0 0.92 CISPEP 2 ALA A 183 PRO A 184 0 2.90 SITE 1 AC1 12 GLY A 132 GLN A 136 VAL A 139 ALA A 150 SITE 2 AC1 12 LYS A 152 MET A 190 GLU A 191 PHE A 192 SITE 3 AC1 12 CYS A 193 GLY A 196 GLN A 197 LEU A 243 CRYST1 57.618 39.617 62.423 90.00 105.47 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017356 0.000000 0.004803 0.00000 SCALE2 0.000000 0.025242 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016622 0.00000